DePuy Synthes Climbs Back to Pre-Pandemic Levels

DePuy Synthes reported 4Q23 orthopedic sales of $2.26 billion, +5.6% compared to the the fourth quarter of 2022. The company generated $8.94 billion in orthopedic sales for the full year, representing growth of +4.1% compared to the prior year.

The company cited the global expansion of its VELYS digital ecosystem and expansion into...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us